IS6990A - 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum - Google Patents

3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum

Info

Publication number: IS6990A
Authority: IS; Iceland
Prior art keywords: diazabicyclo; preparations; antithrombotic compounds; antithrombotic; compounds
Prior art date: 2001-04-12

Application number

IS6990A

Other languages

English (en)

Inventor

Carlsson Hans

Larsson Anette

Original Assignee

Astrazeneca Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-04-12

Filing date

2003-10-10

Publication date

2003-10-10

2001-04-12 Priority claimed from SE0101326A external-priority patent/SE0101326D0/xx

2001-04-12 Priority claimed from SE0101325A external-priority patent/SE0101325D0/xx

2003-10-10 Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab

2003-10-10 Publication of IS6990A publication Critical patent/IS6990A/is

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics

IS6990A 2001-04-12 2003-10-10 3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum IS6990A (is)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
SE0101326A SE0101326D0 (sv)	2001-04-12	2001-04-12	Pharmaceutical formulation
SE0101325A SE0101325D0 (sv)	2001-04-12	2001-04-12	Pharmaceutical formulation
PCT/SE2002/000724 WO2002083687A1 (en)	2001-04-12	2002-04-12	3,7-diazybicyclo [3.3.1] formulations as antiarrhytmic compounds

Publications (1)

Publication Number	Publication Date
IS6990A true IS6990A (is)	2003-10-10

Family

ID=26655442

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS6990A IS6990A (is)	2001-04-12	2003-10-10	3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum

Country Status (23)

Country	Link
US (1)	US20040132798A1 (is)
EP (1)	EP1389211A1 (is)
JP (1)	JP2004525969A (is)
KR (1)	KR20040005917A (is)
CN (1)	CN1279916C (is)
AR (1)	AR035807A1 (is)
BG (1)	BG108235A (is)
BR (1)	BR0208830A (is)
CA (1)	CA2443464A1 (is)
CZ (1)	CZ20032759A3 (is)
EE (1)	EE200300506A (is)
HU (1)	HUP0303481A3 (is)
IL (1)	IL158035A0 (is)
IS (1)	IS6990A (is)
MX (1)	MXPA03009213A (is)
MY (1)	MY141595A (is)
NO (1)	NO20034528L (is)
NZ (1)	NZ528559A (is)
PL (1)	PL367182A1 (is)
RU (1)	RU2003129229A (is)
SK (1)	SK12542003A3 (is)
TW (1)	TWI259836B (is)
WO (1)	WO2002083687A1 (is)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2409552A1 (en)	2001-10-25	2003-04-25	Depomed, Inc.	Gastric retentive oral dosage form with restricted drug release in the lower gastrointestinal tract
US20030091630A1 (en) *	2001-10-25	2003-05-15	Jenny Louie-Helm	Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data
US20060134210A1 (en) *	2004-12-22	2006-06-22	Astrazeneca Ab	Solid dosage form comprising proton pump inhibitor and suspension made thereof
WO2006080508A1 (ja)	2005-01-31	2006-08-03	Bioserentach Co., Ltd.	経皮吸収製剤、経皮吸収製剤保持シート、及び経皮吸収製剤保持用具
KR20080021114A (ko)	2005-06-13	2008-03-06	아스트라제네카 아베	심부정맥의 치료를 위한 신규한 옥사비스피딘 화합물
TW200940110A (en) *	2008-02-22	2009-10-01	Astrazeneca Ab	Pharmaceutical formulation comprising oxabispidines
US10702485B2 (en)	2011-07-09	2020-07-07	Syntrix Biosystems Inc.	Compositions and methods for overcoming resistance to tramadol

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE3732094A1 (de) *	1987-09-24	1989-04-06	Basf Ag	Bispidinderivate als klasse iii-antiarrhythmika
US5110933A (en) *	1989-11-13	1992-05-05	Board Of Regents Of Oklahoma State University	Salts of 3-azabicyclo[3.3.1]nonanes as antiarrhythmic agents, and precursors thereof
DE4402933A1 (de) *	1994-02-01	1995-08-03	Kali Chemie Pharma Gmbh	Neue 3-Benzoyl-3,7-diazabicyclo[3,3,1] nonan-Verbindungen enthaltende Arzneimittel
SE9704709D0 (sv) *	1997-12-17	1997-12-17	Astra Ab	Pharmaceutically active compounds
RU2254333C2 (ru) *	1999-04-09	2005-06-20	Астразенека Аб	Производные адамантана, способ их получения, фармацевтическая композиция на их основе и способы лечения
SE9903759D0 (sv) *	1999-10-18	1999-10-18	Astra Ab	Pharmaceutically active compounds
SE0101327D0 (sv) *	2001-04-12	2001-04-12	Astrazeneca Ab	New crystalline forms
SE0101329D0 (sv) *	2001-04-12	2001-04-12	Astrazeneca Ab	Pharmaceutical formulation

2002
- 2002-04-01 TW TW091106494A patent/TWI259836B/zh not_active IP Right Cessation
- 2002-04-02 AR ARP020101188A patent/AR035807A1/es not_active Application Discontinuation
- 2002-04-10 MY MYPI20021315A patent/MY141595A/en unknown
- 2002-04-12 RU RU2003129229/04A patent/RU2003129229A/ru not_active Application Discontinuation
- 2002-04-12 US US10/474,591 patent/US20040132798A1/en not_active Abandoned
- 2002-04-12 PL PL02367182A patent/PL367182A1/xx unknown
- 2002-04-12 EP EP02723010A patent/EP1389211A1/en not_active Withdrawn
- 2002-04-12 SK SK1254-2003A patent/SK12542003A3/sk unknown
- 2002-04-12 NZ NZ528559A patent/NZ528559A/en unknown
- 2002-04-12 EE EEP200300506A patent/EE200300506A/xx unknown
- 2002-04-12 MX MXPA03009213A patent/MXPA03009213A/es unknown
- 2002-04-12 KR KR10-2003-7013419A patent/KR20040005917A/ko not_active Application Discontinuation
- 2002-04-12 CZ CZ20032759A patent/CZ20032759A3/cs unknown
- 2002-04-12 JP JP2002581442A patent/JP2004525969A/ja not_active Withdrawn
- 2002-04-12 BR BR0208830-4A patent/BR0208830A/pt not_active IP Right Cessation
- 2002-04-12 CN CNB028116348A patent/CN1279916C/zh not_active Expired - Fee Related
- 2002-04-12 WO PCT/SE2002/000724 patent/WO2002083687A1/en not_active Application Discontinuation
- 2002-04-12 IL IL15803502A patent/IL158035A0/xx unknown
- 2002-04-12 CA CA002443464A patent/CA2443464A1/en not_active Abandoned
- 2002-04-12 HU HU0303481A patent/HUP0303481A3/hu unknown
2003
- 2003-10-06 BG BG108235A patent/BG108235A/bg unknown
- 2003-10-09 NO NO20034528A patent/NO20034528L/no not_active Application Discontinuation
- 2003-10-10 IS IS6990A patent/IS6990A/is unknown

Also Published As

Publication number	Publication date
HUP0303481A2 (hu)	2004-01-28
BG108235A (bg)	2005-04-30
JP2004525969A (ja)	2004-08-26
PL367182A1 (en)	2005-02-21
WO2002083687A1 (en)	2002-10-24
US20040132798A1 (en)	2004-07-08
MXPA03009213A (es)	2004-01-29
CA2443464A1 (en)	2002-10-24
CZ20032759A3 (cs)	2004-01-14
TWI259836B (en)	2006-08-11
SK12542003A3 (sk)	2004-03-02
RU2003129229A (ru)	2005-04-10
NZ528559A (en)	2005-03-24
NO20034528D0 (no)	2003-10-09
BR0208830A (pt)	2004-03-09
EE200300506A (et)	2004-02-16
IL158035A0 (en)	2004-03-28
AR035807A1 (es)	2004-07-14
HUP0303481A3 (en)	2005-04-28
CN1279916C (zh)	2006-10-18
MY141595A (en)	2010-05-14
CN1514838A (zh)	2004-07-21
NO20034528L (no)	2003-12-08
KR20040005917A (ko)	2004-01-16
EP1389211A1 (en)	2004-02-18

Publication	Publication Date	Title
IL160708A0 (en)	2004-08-31	1, 6-naphthyridine derivatives as antidiabetics
DE60111734D1 (de)	2005-08-04	[1,4']-bipiperidin verbindungen
HK1061852A1 (en)	2004-10-08	4,5-dihydro-ih-pyrazole derivatives having cb1-antagonistic activity
NO20040540L (no)	2004-02-05	4-amino-6-fenylpyrrolo[2,3-D]pyrimidinderivater.
ZA200108530B (en)	2003-02-03	4,5,6,7-tetrahydroindazole derivatives as antitumor agents.
AU2001230026A1 (en)	2001-08-14	2,4-diaminothiazole derivatives
AU4787301A (en)	2001-10-15	26,27-homologated-20-epi-2-alkyl-19-nor-vitamin d compounds
IS6980A (is)	2003-10-08	3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum
MXPA03005433A (es)	2003-09-10	Compuestos de heterociclilalquilindol o-azaindol como ligandos de 5-hidroxitriptamina-6.
MXPA03009361A (es)	2004-01-29	Compuestos de urea utilies como agentes anti-inflamatorios.
AU2003281694A1 (en)	2004-02-16	6,11-4-carbon bridged ketolides
ZA200203799B (en)	2003-10-29	Antithrombotic compound.
IS6989A (is)	2003-10-10	3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum
IS6990A (is)	2003-10-10	3,7-díasabísýkló [3.3.1] blöndur sem efnasambönd gegn sláttarglöpum
GB0130553D0 (en)	2002-02-06	1,4-Dihydro-1,4-diphenylpyridine derivitives
IL162310A0 (en)	2005-11-20	3,4-Dihydro-1h-isoquinoloin-2-yl-derivatives
AU2002331972A1 (en)	2003-04-14	3,4-methylenedioxy-substituted chalcones as therapeutic agents
MXPA03000664A (es)	2003-06-06	Derivados n-sustituidos del acido 1-amino-1, 1-dialquilcarboxilico.
AU6390001A (en)	2001-11-20	6,10-dimethyl-5,9-undecadien-2-ol
HK1041606A1 (en)	2002-07-12	Process for the preparation of n,n'-carbonylbislactams.
AU2002361027A1 (en)	2003-06-30	Substituted 1,5-diaminopentan-3-ol compounds
PL368536A1 (en)	2005-04-04	Novel 2,4-diaminothiazole derivatives
SI1389213T1 (sl)	2006-08-31	3,7-diazabiciklo(3.3.1)formulacije kot antiaritmicne spojine
PL352760A1 (en)	2003-09-08	Oxathiepino[6,5-b
EG23305A (en)	2004-11-30	Preparation of 1,2-dicloroethane.